|
|
 |
|
Viewing report
|
|
|
|
Asthma Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2006, Pages: 383
This report analyzes the worldwide markets for Asthma Therapeutics in US$ Million. The major therapeutic segments analyzed are Inhaled corticosteroids, Short acting beta agonists, Long acting beta agonists, Combinations, and Anti- leukotrienes. The report provides separate comprehensive analytics for the USA, Canada, Japan, Europe and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 70 companies including many key and niche players worldwide such as Abbott Laboratories, ALTANA Pharma AG, AstraZeneca, Boehringer Ingelheim, Genentech, Inc., GlaxoSmithKline, Merck & Co., Inc., Novartis Pharma AG, Pfizer Inc., Schering-Plough Corporation and 3M. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
Customers who bought this item also bought
European Asthma Therapeutics Markets
U.S. Asthma Therapeutics Market
CNS Therapeutics - Global Strategic Business Report
Asthma & COPD Therapeutics
Commercial Insight: Asthma & COPD - On the verge of generic entry
Breast Cancer Therapeutics - Global Strategic Business Report
Asthma and COPD Drug Discoveries: What the Future Holds
Osteoporosis Therapeutics - Global Strategic Business Report
Prostate Cancer Therapeutics - Global Strategic Business Report
Autoimmune Disease Therapeutics - Global Strategic Business Report
Ovarian Cancer Therapeutics - Global Strategic Business Report
Allergy and Asthma Therapeutics Markets: U.S.
|
|
|
|
